Pros | Lower expense ratio. Beats FD returns for both 3Y & 5Y duration. | Among most bought funds within the category. Larger AUM within category. Beats FD returns for both 3Y & 5Y duration. | ||
Cons | 3Y returns in the bottom 25% of the category. | 3Y returns in the bottom 25% of the category. |
INDMoney rank | 5/8 | 7/8 | ||
Category,Subcateogry | Equity,Sector - Healthcare | Equity,Sector - Healthcare | ||
Fund Age | 7 Years | 12 Years | ||
Fund Size | 2821 Cr | 8346 Cr | ||
Min Investment | SIP ₹99 Lumpsum ₹5000 | SIP ₹100 Lumpsum ₹5000 | ||
Expense Ratio | 0.47% | 0.91% | ||
Exit Load | 1% | 1% | ||
Benchmark Index | BSE Healthcare TR INR | BSE Healthcare TR INR |
No of Holdings | 33 | 41 | ||
Top 5 Holdings | Sun Pharmaceuticals Industries Ltd (12.01%) Divi's Laboratories Ltd (8.88%) Glenmark Pharmaceuticals Ltd (6.41%) Apollo Hospitals Enterprise Ltd (6.23%) Cipla Ltd (5.42%) | Sun Pharmaceuticals Industries Ltd (12.67%) Divi's Laboratories Ltd (8.07%) Lupin Ltd (7.26%) Cipla Ltd (6.29%) Apollo Hospitals Enterprise Ltd (5.97%) | ||
No of Sectors | 2 | 1 | ||
Top 3 Sectors | Health (98.7%) Basic Materials (1.3%) | Health (100%) | ||
Equity % | 99.31% | 99.66% | ||
Debt % | - | - | ||
P/E | 39.26 | 36.22 | ||
P/B | 5.87 | 5.77 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | 0.38% | 1.87% | ||
3-Month Return | 0.19% | 0.16% | ||
6-Month Return | 6.79% | 5.63% | ||
1-Year Return | 6.66% | 5.23% | ||
3-Year Return | 22.56% | 22.67% | ||
5-Year Return | 19.28% | 18.83% |
Sharpe | 0.91 | 0.96 | ||
Alpha | -1.17 | -0.21 | ||
Beta | 1 | 0.91 | ||
Standard Deviation | 16.46 | 15.25 | ||
Information Ratio | -0.53 | -0.48 |
Description | Mirae Asset Healthcare Fund Direct Growth is an equity fund.The fund could potentially beat inflation in the long-run. | Nippon India Pharma Fund - Direct Plan - Growth Plan is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Vrijesh Kasera | Sailesh Raj Bhan,Lokesh Maru,Divya Sharma,Kinjal Desai |